PCI Synthesis Ranks No. 4730 on the 2016 Inc. 5000

Three-Year Sales Growth Enables Company To Reinvest In New Technologies

NEWBURYPORT, Mass., Aug. 18, 2016 /PRNewswire-iReach/ -- Inc. magazine today ranked PCI Synthesis, (www.pcisynthesis.com), a drug substance Contract Manufacturing Organization (CMO) of new chemical entities (NCEs) and generic active pharmaceutical ingredients (APIs), NO. 4730 on its 35th annual Inc. 5000, the most prestigious ranking of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy's most dynamic segment— its independent small businesses. Companies such as Microsoft, Dell, Domino's Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names gained their first national exposure as honorees of the Inc. 5000.

"For a company that's been around for more than 15 years, getting ranked on the Inc. 5000 is a terrific milestone. This is a tribute to our great employees, who not only help us win industry recognition and awards, but, more importantly, provide our small and mid-sized biotech customers with the expertise to manufacture complex small molecules as part of drug discovery and development," said Edward S. Price, president of PCI Synthesis. "Our business success enables us to reinvest in the company with new technologies and updated training for our staff as well as to expand into new product categories like our cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects."

The 2016 Inc. 5000, unveiled online at Inc.com and with the top 500 companies featured in the September issue of Inc. (available on newsstands August 23) is the most competitive crop in the list's history. The average company on the list achieved a mind-boggling three-year growth of 433%. The Inc. 5000's aggregate revenue is $200 billion, and the companies on the list collectively generated 640,000 jobs over the past three years, or about 8% of all jobs created in the entire economy during that period. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.

"The Inc. 5000 list stands out where it really counts," says Inc. President and Editor-In-Chief Eric Schurenberg. "It honors real achievement by a founder or a team of them. No one makes the Inc. 5000 without building something great – usually from scratch. That's one of the hardest things to do in business, as every company founder knows. But without it, free enterprise fails."

The annual Inc. 5000 event honoring all the companies on the list will be held from October 18 through 20, in San Antonio, TX. Speakers include some of the greatest entrepreneurs of this and past generations, such as best-selling author and strategist Tony Robbins, SoulCycle co-founders Elizabeth Cutler and Julie Rice, Cornerstone OnDemand founder, president and CEO Adam Miller, Marvell Technology Group director and co-founder Weili Dai, and New Belgium Brewing co-founder and executive chair Kim Jordan.

About PCI Synthesis

PCI Synthesis is a Pharmaceutical Development CMO (Contract Manufacturing Organization) based in Newburyport, MA and is the largest small molecule drug substance manufacturer in the New England area. PCI is also a commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products for the medical device industry.  As a contract manufacturing organization (CMO), PCI provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules. To learn more about PCI Synthesis, its proprietary NCE development activities and process R&D capabilities please visit www.pcisynthesis.com.

Media Contact: Norman Birnbach, Birnbach Communications, 781-639-6701, birnbach@birnbachcom.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE PCI Synthesis



2017

Tags

Magazines, Publishing & Information Services, Chemical, Awards


Need Help